相关实验视频

Updated: Jun 4, 2025

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

非病毒基因疗法治疗Leber先天性黄斑症:进展和可能性

Latifat Abdulsalam¹, James Mordecai¹, Irshad Ahmad^1,2

¹Department of Bioengineering, King Fahd University of Petroleum and Minerals (KFUPM), Dhahran, Saudi Arabia.

Nanomedicine (London, England)

|December 21, 2024

概括

非病毒基因疗法为治疗勒伯先天性黄斑症 (LCA),一种严重的遗传视网膜疾病提供了更安全的替代方案. 这种方法绕过了与病毒载体相关的风险,为个性化治疗铺平了道路.

科学领域:

眼科医生眼科眼科
遗传学是一个遗传学.
生物技术是生物技术.

背景情况:

勒伯先天性黄斑症 (LCA) 是一组罕见的,遗传性视网膜疾病,导致儿童早期严重的视力丧失.
了解LCA的遗传基础使得有针对性的治疗干预措施成为可能.
目前的病毒载体基因传递方法面临挑战,包括安全问题,有限的载荷能力和基因组集成的潜力.

研究的目的:

审查LCA和相关突变的遗传基础.
探索各种非病毒基因传递系统作为LCA治疗中病毒载体的替代方案.
讨论最近的进展,临床试验和LCA非病毒基因治疗的未来方向.

主要方法:

对LCA遗传学和基因治疗方法的现有文献的审查.
分析非病毒基因传递系统,包括纳米粒子和基于脂质的载体.
对评估LCA非病毒基因疗法的临床前和临床研究的审查.

主要成果:

非病毒基因传递方法 (纳米颗粒,聚合物,脂质) 为病毒载体提供了更安全,更灵活的替代方案.
这些方法减轻了免疫性和随机基因组集成的风险,这对于遗传性视网膜疾病至关重要.
新兴技术和跨学科方法正在推进个性化的LCA治疗.

结论:

非病毒基因疗法为勒伯先天性黄斑病提供了一个有希望和更安全的治疗策略.
对非病毒传递系统的持续研究和开发对于有效的LCA治疗至关重要.
未来的方向包括整合基因编辑技术和促进个人化医学合作.

关键词:

在DNA纳米粒子中.勒贝尔的先天性黄斑病.退化退化退化基因治疗的基因疗法遗传学遗传学遗传学是一个非病毒载体的非病毒载体眼部基因疗法眼部基因疗法

更多相关视频

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models

Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models

Published on: March 16, 2022

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.